(1)
Efficacy of Neuroprotective Treatment Including Pyrimidine Nucleotides in Secondary Uveitic Glaucoma. Ukr. j. ophthalmol. 2026, No. 2, 29-33. https://doi.org/10.31288/oftalmolzh/2018/2/2933.